Revenue, last quarter
$183.6M
+15.6% vs same quarter last year
Net income
−$15.7M
+61% vs same quarter last year
EPS, diluted
−$0.13
+63.9% vs same quarter last year
Operating cash flow
$8.1M
+151% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $655.4M | −$136.2M |
| FY24 | $605.2M | −$169M |
| FY23 | $509.3M | −$207M |
| FY22 | $537.8M | −$93M |
| FY21 | $535M | −$58M |
| FY20 | $494.4M | $19.8M |
| FY19 | $351.3M | −$7.2M |
| FY18 | $248.1M | −$63.6M |
| FY17 | $177M | −$61.7M |
| FY16 | $82.9M | −$131.8M |
| FY15 | $33.1M | −$111.6M |
| FY14 | $15.5M | −$80.7M |
| FY13 | $10.4M | −$77.4M |
| FY12 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 74.5% | −23.5% | −20.8% |
| FY24 | 77.3% | −28.2% | −27.9% |
| FY23 | 74.8% | −45.7% | −40.6% |
| FY22 | 78.6% | −16.6% | −17.3% |
| FY21 | 78.5% | −8.3% | −10.8% |
| FY20 | 78.5% | 6.1% | 4% |
| FY19 | 74.8% | −0.3% | −2.1% |
| FY18 | 67.7% | −13.6% | −25.6% |
| FY17 | 68.6% | −22.2% | −34.8% |
| FY16 | 44.2% | −139.1% | −159.1% |
| FY15 | 37.7% | −314.3% | −337.2% |
| FY14 | 35.2% | −517.5% | −520.9% |
| FY13 | 32.3% | −622.3% | −746.9% |
| FY12 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$75.7M |
| FY24 | −$69.2M |
| FY23 | −$100.4M |
| FY22 | $9.4M |
| FY21 | $58.6M |
| FY20 | $84.2M |
| FY19 | $16.1M |
| FY18 | −$8.6M |
| FY17 | −$40.5M |
| FY16 | −$113.3M |
| FY15 | −$104.6M |
| FY14 | −$75.1M |
| FY13 | −$54.9M |
| FY12 | - |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | - |
| FY24 | - |
| FY23 | - |
| FY22 | - |
| FY21 | - |
| FY20 | - |
| FY19 | - |
| FY18 | - |
| FY17 | - |
| FY16 | - |
| FY15 | $5K |
| FY14 | - |
| FY13 | - |
| FY12 | - |
- NovoCure
- Healthcare median
Show the numbers
| Year | NovoCure | Healthcare median |
|---|---|---|
| FY25 | −20.8% | −40.6% |
| FY24 | −27.9% | −60.7% |
| FY23 | −40.6% | −97.1% |
| FY22 | −17.3% | −128.5% |
| FY21 | −10.8% | −129.2% |
| FY20 | 4% | −136.5% |
| FY19 | −2.1% | −133.7% |
| FY18 | −25.6% | −173.4% |
| FY17 | −34.8% | −176.7% |
| FY16 | −159.1% | −164.8% |
| FY15 | −337.2% | −183.4% |
| FY14 | −520.9% | −133% |
| FY13 | −746.9% | −88.5% |
| FY12 | - | −87.4% |
News
No stories filed under NovoCure yet - coverage appears here as the news feed clusters it.